2008 APS March Meeting
Volume 53, Number 2
Monday–Friday, March 10–14, 2008;
New Orleans, Louisiana
Session S16: Focus Session: General Techniques and Radiation Therapies in Biological Physics
2:30 PM–5:30 PM,
Wednesday, March 12, 2008
Morial Convention Center
Room: 208
Sponsoring
Unit:
DBP
Chair: Paul Gueye, Hampton University
Abstract ID: BAPS.2008.MAR.S16.3
Abstract: S16.00003 : Technological Advances in Proton Therapy
3:42 PM–4:18 PM
Preview Abstract
Abstract
Author:
James McDonough
(University of Pennsylvania)
Proton therapy has interested radiation oncologists since the 1946 paper by
Robert R. Wilson describing the energy deposition of proton beams and
suggesting it would be more suitable for radiation treatments than beams of
x-rays. For all its proposed benefits, only 25,000 or so cancer patients
worldwide have been treated with high-energy proton beams over the last
fifty years. However, during the past decade that number has started to
rapidly increase. In the United States alone the number of dedicated
facilities has grown from two to five in the last three years and will
likely double again by the end of the current decade. We will soon be
treating as many patients in one year as was treated during the first fifty
years of proton therapy. Surprisingly, the reason is because of what has
been happening in x-ray radiotherapy.
Conventional radiotherapy underwent a dramatic change during the past decade
with the introduction of multiple advances in imaging technology and beam
delivery methods. The imaging advances include both imaging for treatment
planning (multislice CT systems, high resolution MRI, and increasing use of
PET) and imaging of the target location in the treatment room. The treatment
delivery advances, dominated by methods that permit intensity modulated beam
delivery, were made possible by increased computational power and more
computer control of the treatment delivery.
These imaging and beam delivery advances should benefit proton therapy
treatments even more than x-ray treatments because of the better
conformation of dose to the target that one can achieve with proton beams.
However, because of the small size of the proton therapy community it has
had difficulty implementing some of the advances made in x-ray therapy. The
treatment planning imaging is also used by proton therapy but the
on-treatment imaging and the intensity modulation often must be specially
developed for each proton therapy system. This talk will present the
developments in these areas that are expected to be implemented in the next
few years.
To cite this abstract, use the following reference: http://meetings.aps.org/link/BAPS.2008.MAR.S16.3